Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Warren B Bilker

Showing results (51-60 of 290) with videos related to

Pageof 29
Sort By:
Pharmacoepidemiology and Drug Safety|July 29, 2011
Antidepressants and the risk of sudden cardiac death and ventricular arrhythmiaCharles E Leonard, Warren B Bilker, Craig Newcomb, et al.
Infection Control and Hospital Epidemiology|September 29, 2018
Blood culture utilization at an academic hospital: Addressing a gap in benchmarkingAnnie I Chen, Warren B Bilker, Keith W Hamilton, et al.
Pharmacoepidemiology and Drug Safety|July 15, 2011
Temporal and within practice variability in the health improvement networkKevin Haynes, Warren B Bilker, Tom R Tenhave, et al.
BMJ Open|February 20, 2019
Outdoor temperature and survival benefit of empiric potassium in users of furosemide in US Medicaid enrollees: a cohort studyYoung Hee Nam, Warren B Bilker, Charles E Leonard, et al.
Antimicrobial Agents and Chemotherapy|July 25, 2012
Effect of reduced vancomycin susceptibility on clinical and economic outcomes in Staphylococcus aureus bacteremiaJennifer H Han, Kara B Mascitti, Paul H Edelstein, et al.
Frontiers in Aging Neuroscience|October 30, 2023
Unique characteristics of end-of-life hospitalizations in Parkinson diseaseWhitley W Aamodt, Nabila Dahodwala, Warren B Bilker, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 6, 2005
Association between fluoroquinolone resistance and mortality in Escherichia coli and Klebsiella pneumoniae infections: the role of inadequate empirical antimicrobial therapyEbbing Lautenbach, Joshua P Metlay, Warren B Bilker, et al.
BMC Cardiovascular Disorders|December 2, 2022
Prevalence of the metabolic syndrome and associated factors among inpatients with severe mental illness in Botswana: a cross-sectional studyBilly M Tsima, Philip Opondo, Mosepele Mosepele, et al.
The Pediatric Infectious Disease Journal|July 13, 2004
Risk factors for disseminated candidiasis in children with candidemiaTheoklis E Zaoutis, H Mollie Greves, Ebbing Lautenbach, et al.
The Journal of Infectious Diseases|September 12, 2012
Risk factors for efflux pump overexpression in fluoroquinolone-resistant Escherichia coliJennifer H Han, Irving Nachamkin, Pam Tolomeo, et al.
Pageof 29

Showing results (51-60 of 290) with videos related to

Sort By:
Pageof 29
Pharmacoepidemiology and Drug Safety|July 29, 2011
Antidepressants and the risk of sudden cardiac death and ventricular arrhythmiaCharles E Leonard, Warren B Bilker, Craig Newcomb, et al.
Infection Control and Hospital Epidemiology|September 29, 2018
Blood culture utilization at an academic hospital: Addressing a gap in benchmarkingAnnie I Chen, Warren B Bilker, Keith W Hamilton, et al.
Pharmacoepidemiology and Drug Safety|July 15, 2011
Temporal and within practice variability in the health improvement networkKevin Haynes, Warren B Bilker, Tom R Tenhave, et al.
BMJ Open|February 20, 2019
Outdoor temperature and survival benefit of empiric potassium in users of furosemide in US Medicaid enrollees: a cohort studyYoung Hee Nam, Warren B Bilker, Charles E Leonard, et al.
Antimicrobial Agents and Chemotherapy|July 25, 2012
Effect of reduced vancomycin susceptibility on clinical and economic outcomes in Staphylococcus aureus bacteremiaJennifer H Han, Kara B Mascitti, Paul H Edelstein, et al.
Frontiers in Aging Neuroscience|October 30, 2023
Unique characteristics of end-of-life hospitalizations in Parkinson diseaseWhitley W Aamodt, Nabila Dahodwala, Warren B Bilker, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 6, 2005
Association between fluoroquinolone resistance and mortality in Escherichia coli and Klebsiella pneumoniae infections: the role of inadequate empirical antimicrobial therapyEbbing Lautenbach, Joshua P Metlay, Warren B Bilker, et al.
BMC Cardiovascular Disorders|December 2, 2022
Prevalence of the metabolic syndrome and associated factors among inpatients with severe mental illness in Botswana: a cross-sectional studyBilly M Tsima, Philip Opondo, Mosepele Mosepele, et al.
The Pediatric Infectious Disease Journal|July 13, 2004
Risk factors for disseminated candidiasis in children with candidemiaTheoklis E Zaoutis, H Mollie Greves, Ebbing Lautenbach, et al.
The Journal of Infectious Diseases|September 12, 2012
Risk factors for efflux pump overexpression in fluoroquinolone-resistant Escherichia coliJennifer H Han, Irving Nachamkin, Pam Tolomeo, et al.
Pageof 29